Studying heart changes after tricuspid valve replacement
Part of Heart & circulation clinical trials.
This study looks at how the heart adjusts after a procedure to replace the tricuspid valve (the valve between the right upper and lower heart chambers). It focuses on patients who need medication to support their blood pressure within 24 hours after the procedure, to better understand and manage this unstable period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a tricuspid valve replacement with a specific type of valve called the Evoque system (or another valve used under special permission).
- Within 24 hours after the procedure, you needed medicine to raise your blood pressure because your heart was not pumping steadily.
- This drop in blood pressure was not caused by a major problem during the procedure, like bleeding or fluid around the heart.
- You did not receive blood pressure medicine just as a routine part of recovery or to support the right side of your heart without signs of poor blood flow.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how heart devices like pacemakers affect the tricuspid valve over time. It uses ultrasound to check valve function and see if the device causes any problems.
This study tests a new, less invasive way to replace the tricuspid valve (the valve between the right upper and lower heart chambers) in people with severe leakage. The valve is delivered through a vein in the neck or leg, avoiding open-heart surgery.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
This trial tests a new device called Laplace TTVR to replace a leaky tricuspid valve in the heart without open surgery. It is for people with severe symptoms despite medical treatment.
This trial tests a new device called TricValve, which is placed through a catheter (a thin tube) to fix a leaky tricuspid valve on the right side of the heart. It aims to reduce blood flowing backward and improve heart failure symptoms for people who can't have open-heart surgery and haven't been helped by other catheter treatments.
This study looks at whether fixing the tricuspid valve at the same time as left heart surgery is beneficial for patients with mild tricuspid regurgitation. It may help improve heart function and reduce future symptoms.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.